TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VERA

Vera Therapeutics Inc

Healthcare · Biotechnology

30.40$ -1.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Vera Therapeutics Inc (VERA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 533 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VERA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
176 176 419 397 369 656 610 579 518 735 622 533
172 172 416 395 364 651 606 571 506 729 616 527
27 46 69 25 27 93 55 49 58 355 114 49
160 161 404 384 353 641 590 557 497 715 597 499
– – 1.6 2.0 2.0 3.8 3.6 4.2 3.4 3.3 3.9 –
52 74 66 69 80 79 75 110 119 130 122 125
25 22 15 18 26 25 22 34 42 53 45 48
2.5 2.4 2.3 2.1 1.9 1.5 1.2 0.9 0.5 0.5 – –
12 11 5.2 4.7 4.6 7.7 9.3 13 18 22 14 15
25 50 50 50 50 51 51 74 75 75 75 75
124 102 354 328 289 577 535 468 399 605 500 408
-283 -309 -337 -371 -418 -461 -513 -589 -670 -761 -882 -991
44 44 51 55 55 55 64 64 64 64 71 72

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?